Healthcare - Biotechnology - NASDAQ - US
$ 3.46
2.98 %
$ 173 M
Market Cap
-2.22
P/E
BALANCE SHEET
94.5 M
ASSETS
57.3 M
LIABILITIES
37.2 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
scPharmaceuticals Inc.
| Current Assets | 92.9 M |
| Cash & Short-Term Investments | 76 M |
| Receivables | 4.49 M |
| Other Current Assets | 12.4 M |
| Non-Current Assets | 1.54 M |
| Long-Term Investments | 0 |
| PP&E | 1.46 M |
| Other Non-Current Assets | 82 K |
| Current Liabilities | 13.1 M |
| Accounts Payable | 4 M |
| Short-Term Debt | 352 K |
| Other Current Liabilities | 8.78 M |
| Non-Current Liabilities | 44.1 M |
| Long-Term Debt | 40.1 M |
| Other Non-Current Liabilities | 4.03 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Cash & Cash Equivalents | 46.8 | 71.1 | 74.3 | 105.3 | 72.8 | 89.7 | 118.3 | 39.3 | 1.6 |
| Short Term Investments | 29.2 | 47.1 | 1.0 | 33.3 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.5 | 0 | 0 | 0 | 0.3 | 0.5 | 0.7 | 0.3 | 0.1 |
| Inventory | 8.8 | 1.2 | 0 | 0 | 2.4 | 1.6 | 0.8 | 0.1 | 0.1 |
| Other Current Assets | 3.6 | 2.5 | 3.0 | 2.7 | 2.7 | 1.9 | 0.9 | 0.1 | 0.1 |
| Total Current Assets | 92.9 | 123.3 | 78.3 | 107.8 | 75.6 | 91.9 | 119.9 | 39.7 | 1.8 |
| PP&E | 1.5 | 0.6 | 0.5 | 0.9 | 1.3 | 1.7 | 2.0 | 26 K | 23 K |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0.2 | 0.2 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 82 K | 0.3 | 0.3 | 0.1 | 0.1 | 0.2 | 0.2 | 6 K | 5 K |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 94.5 | 124.2 | 79.0 | 109.0 | 77.3 | 93.8 | 122.0 | 39.8 | 1.8 |
| LIABILITIES | |||||||||
| Accounts Payable | 4.0 | 1.5 | 0.5 | 1.7 | 1.1 | 0.6 | 1.6 | 1.5 | 0.7 |
| Short Term Debt | 0.4 | 1.1 | 10.8 | 3.3 | 0.8 | 3.2 | 0.6 | 0 | 0 |
| Other Current Liabilities | 8.8 | 4.7 | 3.5 | 4.3 | 3.2 | 2.8 | 2.9 | 2.2 | 1.3 |
| Total Current Liabilities | 13.1 | 7.4 | 14.8 | 9.3 | 5.2 | 6.7 | 5.2 | 3.7 | 2.0 |
| Long Term Debt | 40.1 | 36.8 | 7.4 | 17.3 | 19.9 | 8.2 | 10.8 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 4.0 | 7.5 | 0.4 | 0.2 | 0.8 | 0.2 | 52 K | 73.1 | 18.1 |
| Total Liabilities | 57.3 | 51.8 | 22.6 | 26.9 | 25.9 | 15.0 | 16.1 | 76.8 | 20.1 |
| EQUITY | |||||||||
| Common Stock | 4 K | 3 K | 3 K | 3 K | 2 K | 2 K | 2 K | 1 K | 1 K |
| Retained Earnings | (281.3) | (226.5) | (189.7) | (161.7) | (129.5) | (96.5) | (67.0) | (43.2) | (18.8) |
| Other Accumulative Comprehensive Income/Loss | 1 K | 32 K | 1 K | 1 K | 0 | (0.6) | 26 K | 9 K | 4 K |
| Total Equity | 37.2 | (226.5) | (189.7) | (161.7) | (129.5) | (96.5) | 106.0 | (37.1) | (18.2) |
| Total Liabilities and Equity | 94.5 | (174.8) | (167.1) | (134.8) | (103.5) | (81.4) | 122.0 | 39.8 | 1.8 |
| SHARES OUTSTANDING | |||||||||
| Common Shares Outstanding | 38.5 | 28.4 | 27.4 | 24.6 | 18.6 | 18.6 | 3.0 | 11.2 | 11.2 |